Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia.

about

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia.

Item

http://www.wikidata.org/entity/Q54109565

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Effects and potential mechanis ...... LA2 in rats with dyslipidemia.

@en

Effects and potential mechanis ...... LA2 in rats with dyslipidemia.

@nl

type

Item

label

Effects and potential mechanis ...... LA2 in rats with dyslipidemia.

@en

Effects and potential mechanis ...... LA2 in rats with dyslipidemia.

@nl

prefLabel

Effects and potential mechanis ...... LA2 in rats with dyslipidemia.

@en

Effects and potential mechanis ...... LA2 in rats with dyslipidemia.

@nl

P1476

Effects and potential mechanis ...... LA2 in rats with dyslipidemia.

@en

P2093

Anping Cai

http://www.w3.org/2001/XMLSchema#string

Dongdan Zheng

http://www.w3.org/2001/XMLSchema#string

Fanfang Zeng

http://www.w3.org/2001/XMLSchema#string

Liwen Li

http://www.w3.org/2001/XMLSchema#string

Rulin Xu

http://www.w3.org/2001/XMLSchema#string

Weiyi Mai

http://www.w3.org/2001/XMLSchema#string

Yingling Zhou

http://www.w3.org/2001/XMLSchema#string

Zhuocheng Mai

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of statin therapy on lipoprotein associated phospholipase A2 levels

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.

Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function.

Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.

Rho GTPases, statins, and nitric oxide.

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community-based prevention clinic.

P304

629-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2017.69494

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29765452

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias

P932

5949919

http://www.w3.org/2001/XMLSchema#string